Viewing Study NCT06733233


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-03-13 @ 9:44 PM
Study NCT ID: NCT06733233
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-13
First Post: 2024-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer
Sponsor: Guangzhou Women and Children's Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module